stress hyperglycemia. Hyperglycaemia, unspecified
Conditions
Interventions
Control group: BG control by Insulin Sliding Scale
Intervention group: BG control by Continuous Insulin Infusion.
Treatment - Drugs
Control group: BG control by Insulin Sliding Scale
Intervention group: BG control by Continuous Insulin Infusion
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 139 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 1) Blood glucose more than 180 mg/dL in ICU 2) No diabetes history 3) At least 18 years old Exclusion criteria: 1) Less than 18 years old 2) Diabetes diagnosis during the study 3) Lack of patient or patient's relatives Consent 4) Transport to other units or death within 8 days of entrance
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Malondialdehyde (MDA). Timepoint: Baseline, 3rd and 7th days of study. Method of measurement: Biochemistry.;Protein Carbonyl (PCO). Timepoint: Baseline, 3rd and 7th days of study. Method of measurement: Biochemistry. | — |
Secondary
| Measure | Time frame |
|---|---|
| Sequential Organ Failure Assessment (SOFA). Timepoint: Daily. Method of measurement: Scoring system (consists of 6 scoring criteria).;ICU stay. Timepoint: Daily. Method of measurement: Days.;Daily insulin requirement. Timepoint: Daily. Method of measurement: Insulin unit.;Blood glucose. Timepoint: Daily average. Method of measurement: Every hour to every six hour, mg/dL. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Sistanizad
Faculty of Pharmacy, Shahid Beheshti University of Medical Sciences
Outcome results
None listed